Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
antibiotic, conference, Director, dispute, estate, exploit, Fast, predecessor, QIDP, refused, repaid, Republic, resolved, Scott, Tarriff, Virginia, written
Removed:
ALIMTA, antiemetic, assume, attract, branded, broadly, brought, cell, chemical, combined, commercialized, complying, confidential, continuing, developed, eliminate, England, evolve, expect, forced, foregoing, formulation, frequent, identifying, induction, infusion, initiation, intend, Justice, large, lung, maintenance, medical, mesothelioma, mitigate, nausea, offer, organized, percent, plc, postoperative, presence, rapid, recently, referred, registered, rely, remote, RI, safety, sedation, senior, situation, slowdown, strong, successfully, supporting, technology, terminate, treat, unable, unknown, utilization, vomiting
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view